Effectiveness of concurrent radiation therapy with UFT or TS-1 for T2N0 glottic cancer in Japan

Anticancer Research

Volumn 27, Issue 5 B, 2007, Pages 3497-3500

  Niibe, Yuzuru ^a,c   Nakayama, Meijin ^a   Matsubayashi, Takashi ^a   Takahashi, Hiroomi ^a   Kitano, Masahi ^b   Okamoto, Makito ^a   Hayakawa, Kazushige ^a  

^a KITASATO UNIVERSITY   (Japan)

^b SAGAMIHARA NATIONAL HOSPITAL   (Japan)

^c KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemoradiotherapy; Peroral chemotherapy; T2N0 glottic cancer; TS 1; UFT

Indexed keywords

CISPLATIN; DOCETAXEL; FLUOROURACIL; NEDAPLATIN; UFT;

ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEAD AND NECK CANCER; HUMAN; JAPAN; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; JAPAN; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SILICATES; SURVIVAL ANALYSIS; TEGAFUR; TITANIUM;

EID: 35348987618     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Mendenhall WM, Hinerman RW, Amdur RJ, Mancuso AA and Villarret DB: Larynx In: Principles and Practice of Radiation Oncology (4th ed.). Perez CA, Brady LW, Halperin EC and Schmidt-Ullrich RK (eds.). Philadelphia, pp. 1094-1116, 2004.
2. Brumund KT, Gutierez-Fonseca R, Garcia D, Babin E, Hans S and Laccourreye O: Frontolateral vertical partial laryngectomy without tracheotomy for invasive squamous cell carcinoma of the true vocal cord: a 25-year experience. Ann Otol Rhinol Laryngol 114: 314-322, 2005.
3. Kumamoto Y, Masuda M, Kuratomi Y, Toh S, Shinokuma A, Chujo K, Yamamoto T and Komiyama S: "FAR" chemoradiotherapy improves laryngeal preservation rates in patients with T2N0 glottic carcinoma. Head Neck 24: 637-642, 2002.
4. Laccourreye O, Diaz EM Jr, Bassot V, Musatello L, Garcia D and Brasnu D: A multimodal strategy for the treatment of patients with T2 invasive squamous cell carcinoma of the glottis. Cancer 85: 40-46, 1999.
5. Laccourreye O, Weinstein G, Brasnu D, Trotoux J and Laccourreye H: Vertical partial laryngectomy: a critical analysis of local recurrence. Ann Otol Rhinol Laryngol 100: 68-71, 1991.
6. Amornmarn R, Prempree T, Viravathana T, Donavanik V and Weizenberg MJ: A therapeutic approach to early vocal cord carcinoma. Acta Radiol Oncol 24: 321-325, 1985.
7. Harwood AR, Hawkins NV, Rider WD and Bryce DP: Radiotherapy of early glottic cancer-I. Int J Radiat Oncol Biol Phys 5: 473-476, 1979.
8. Mendenhall WM, Amdur RJ, Morris CG and Hinerman RW: T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy. J Clin Oncol 19: 4029-4036, 2001.
9. Mendenhall WM, Parsons JT, Million RR and Fletcher GH: T1-T2 squamous cell carcinoma of the glottic larynx treated with radiation therapy: relationship of dose-fractionation factors to local control and complications. Int J Radiat Oncol Biol Phys 15: 1267-1273, 1988.
10. Nishimura Y, Nagata Y, Okajima K, Mitsumori M, Hiraoka M, Masunaga S, Ono K, Shoji K and Kojima H: Radiation therapy for T1,2 glottic carcinoma: impact of overall treatment time on local control. Radiother Oncol 40: 225-232, 1996.
11. Jones AS, Fish B, Fenton JE and Husband DJ: The treatment of early laryngeal cancers (T1-T2 N0): surgery or irradiation? Head Neck 26: 127-135, 2004.
12. Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR and Ang KK: Results of radiotherapy for T2N0 glottic carcinoma: does the "2" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 55: 322-328, 2003.
13. Niibe Y, Karasawa K, Mitsuhashi T and Tanaka Y: Hyperfractionated radiation therapy for hypopharyngeal Carcinoma compared with conventional radiation therapy: local control, laryngeal preservation and overall survival. Jpn J Clin Oncol 33: 450-455, 2003.
14. Niibe Y, Karasawa K, Mitsuhashi T, Miyashita H and Tanaka Y: Hyperfractionated radiation therapy for oropharyngeal carcinoma in a Japanese population. Jpn J Clin Oncol 34: 312-315, 2004.
15. Yu E, Shenouda G, Beaudet MP and Black MJ: Impact of radiation therapy fraction size on local control of early glottic carcinoma. Int J Radiat Oncol Biol Phys 37: 587-591, 1997.
16. Akimoto T, Nokana, T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K, Furuya N, Hayakawa K, Mitsuhashi N and Nakano T: Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys 64: 995-1001, 2006.
17. Liu G, Franssen E, Fitch MI and Warner E: Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15: 110-115, 1997.
18. Hyodo I, Nishina T, Moriwaki T, Endo S, Terao T, Hirao K, Nasu J, Hirasaki S, Endo H, Masumoto T, Tajiri H and Kurita A: A phase I study of S-1 combined with weekly cisplatin for metastatic gastric cancer in an outpatient setting. Eur J Cancer 39: 2328-2333, 2003.
19. Kawahara M, Furuse K, Segawa Y Yoshimori K, Matsui K, Kudoh S, Hasegawa K and Niitani H: Phase II study of S-1, a novel oral fluorouracil, in advanced non-small cell lung cancer. Br J Cancer 85: 939-943, 2001.
20. Ohtsu A, Baba H, Sakata Y, Mitachi Y, Horikoshi N, Sugimachi K and Taguchi T: Phase II study of S-1, a novel oral fluorophyrimidine derivative, in patients with metastatic colorectal carcinoma. S-1 Cooperative Colorectal Carcinoma Study Group. Br J Cancer 83: 141-145, 2000.
21. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT and Prosnitz LR: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Eng J Med 338: 1798-1804, 1998.
22. Ita M, Okafuji M, Fukuda K, Mitsuoka K, Hanakita T and Hayatsu Y: Concurrent chemoradiotherapy with new platinum compound nedaplatin in oral cancer. Oral Oncol 39: 144-149, 2003.
23. Karasawa K, Shinoda H, Katsui K, Seki K, Kohno M, Hanyu N, Nasu S, Muramatsu H, Maebayashi K, Mitsuhashi N and Yoshihara T: Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancer. Anticancer Res 22: 3785-3788, 2002.